Use of 18 F-NaF PET in the staging of skeletal metastases of newly diagnosed, high-risk prostate cancer patients: a nationwide cohort study.
Anna Winther MogensenLars J PetersenChristian Torp-PedersenMette NørgaardMarie T PankHelle Damgaard ZachoPublished in: BMJ open (2022)
F-NaF PET did not display a lower risk of developing SREs after prostatectomy compared with patients undergoing bone scintigraphy. The survival rates were similar between the two groups.